Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis

JACC: Cardiovascular Imaging

Volumn 9, Issue 2, 2016, Pages 126-138

  Ternacle, Julien ^a,b,c,d,e,f   Bodez, Diane ^a,b,c,d,e,f   Guellich, Aziz ^a,b,c,d,e,f   Audureau, Etienne ^b,c   Rappeneau, Stephane ^a,b,c,d,e,f   Lim, Pascal ^a,b,c,e,f   Radu, Costin ^a,b,c,e,f   Guendouz, Soulef ^a,b,c,d,e,f   Couetil, Jean Paul ^b,c,e   Benhaiem, Nicole ^c   Hittinger, Luc ^a,b,c,d,e,f   Dubois Randé, Jean Luc ^a,b,c,d,e,f   Plante Bordeneuve, Violaine ^a,b,c,f   Mohty, Dania ^g   Deux, Jean François ^a,b,c,f   Damy, Thibaud ^a,b,c,d,e,f  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b Mondor Amyloidosis Network   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d INSERM U955   (France)

^e DHU ATVB   (France)

^f INSERM   (France)

^g DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

amyloid; heart failure; prognosis; speckle tracking

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMYLOID; GADOLINIUM; PREALBUMIN;

AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOCARDIOGRAPH; FEMALE; FOLLOW UP; HEART AMYLOIDOSIS; HEART DISEASE; HEART GRAFT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; INTERVENTRICULAR SEPTUM; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LONGITUDINAL LEFT VENTRICULAR DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; TWO DIMENSIONAL ECHOCARDIOGRAPHY; AMYLOIDOSIS; BIOMECHANICS; BIOPSY; CARDIAC MUSCLE; CARDIOMYOPATHIES; COMPLICATION; DIAGNOSTIC IMAGING; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; MECHANICAL STRESS; MIDDLE AGED; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMYLOIDOSIS; BIOMECHANICAL PHENOMENA; BIOPSY; CARDIOMYOPATHIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STRESS, MECHANICAL; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84953221930     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2015.05.014     Document Type: Article

References (38)

1. 1 Falk, R.H., Dubrey, S.W., Amyloid heart disease. Prog Cardiovasc Dis 52 (2010), 347–361.
2. 2 Merlini, G., Bellotti, V., Molecular mechanisms of amyloidosis. N Engl J Med 349 (2003), 583–596.
3. 3 Gray Gilstrap, L., Niehaus, E., Malhotra, R., et al. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis. J Heart Lung Transplant 33 (2014), 149–156.
4. 4 Vikram, C.S., Removing the diffraction halo effect in speckle photography of sinusoidal vibration. Appl Optics 29 (1990), 3572–3573.
5. 5 Fontana, M., Banypersad, S.M., Treibel, T.A., et al. Native T1 mapping in transthyretin amyloidosis. J Am Coll Cardiol Img 7 (2014), 157–165.
6. 6 Koyama, J., Falk, R.H., Prognostic significance of strain Doppler imaging in light-chain amyloidosis. J Am Coll Cardiol Img 3 (2010), 333–342.
7. 7 Syed, I.S., Glockner, J.F., Feng, D., et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. J Am Coll Cardiol Img 3 (2010), 155–164.
8. 8 Deux, J.F., Damy, T., Rahmouni, A., Mayer, J., Plante-Bordeneuve, V., Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study. Amyloid 21 (2014), 246–255.
9. 9 Perugini, E., Rapezzi, C., Piva, T., et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 92 (2006), 343–349.
10. 10 Cerqueira, M.D., Weissman, N.J., Dilsizian, V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002), 539–542.
11. 11 Phelan, D., Collier, P., Thavendiranathan, P., et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98 (2012), 1442–1448.
12. 12 Glaudemans, A.W., van Rheenen, R.W., van den Berg, M.P., et al. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Amyloid 21 (2014), 35–44.
13. 13 Tedford, R.J., Hassoun, P.M., Mathai, S.C., et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 125 (2012), 289–297.
14. 14 Flett, A.S., Hasleton, J., Cook, C., et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. J Am Coll Cardiol Img 4 (2011), 150–156.
15. 15 Belkin, R.N., Kupersmith, A.C., Khalique, O., et al. A novel two-dimensional echocardiographic finding in cardiac amyloidosis. Echocardiography 27 (2010), 1171–1176.
16. 16 Quarta, C.C., Solomon, S.D., Uraizee, I., et al. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation 129 (2014), 1840–1849.
17. 17 Grossman, W., Jones, D., McLaurin, L.P., Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56 (1975), 56–64.
18. 18 Jiang, L., Huang, Y., Hunyor, S., dos Remedios, C.G., Cardiomyocyte apoptosis is associated with increased wall stress in chronic failing left ventricle. Eur Heart J 24 (2003), 742–751.
19. 19 Hosch, W., Kristen, A.V., Libicher, M., et al. Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings. Amyloid 15 (2008), 196–204.
20. 20 Liao, R., Jain, M., Teller, P., et al. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation 104 (2001), 1594–1597.
21. 21 Brenner, D.A., Jain, M., Pimentel, D.R., et al. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circulation research 94 (2004), 1008–1010.
22. 22 Shi, J., Guan, J., Jiang, B., et al. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci U S A 107 (2010), 4188–4193.
23. 23 Austin, B.A., Duffy, B., Tan, C., Rodriguez, E.R., Starling, R.C., Desai, M.Y., Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis. Am J Cardiol 103 (2009), 1429–1433.
24. 24 Migrino, R.Q., Mareedu, R.K., Eastwood, D., Bowers, M., Harmann, L., Hari, P., Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis. J Am Soc Echocardiogr 22 (2009), 1396–1402.
25. 25 Palladini, G., Campana, C., Klersy, C., et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 107 (2003), 2440–2445.
26. 26 Dispenzieri, A., Gertz, M.A., Kyle, R.A., et al. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 104 (2004), 1881–1887.
27. 27 Kristen, A.V., Giannitsis, E., Lehrke, S., et al. Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay. Blood 116 (2010), 2455–2461.
28. 28 Damy, T., Deux, J.F., Moutereau, S., et al. Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis. Amyloid 20 (2013), 212–220.
29. 29 Sattianayagam, P.T., Hahn, A.F., Whelan, C.J., et al. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant. Eur Heart J 33 (2012), 1120–1127.
30. 30 Roig, E., Almenar, L., Gonzalez-Vilchez, F., et al. Outcomes of heart transplantation for cardiac amyloidosis: subanalysis of the Spanish Registry for Heart Transplantation. Am J Transplant 9 (2009), 1414–1419.
31. 31 Cramariuc, D., Cioffi, G., Rieck, A.E., et al. Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS substudy. J Am Coll Cardiol Img 2 (2009), 390–399.
32. 32 Kinnunen, P., Vuolteenaho, O., Ruskoaho, H., Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 132 (1993), 1961–1970.
33. 33 Liu, D., Hu, K., Niemann, M., et al. Impact of regional left ventricular function on outcome for patients with AL amyloidosis. PloS One, 8, 2013, e56923.
34. 34 Koyama, J., Ray-Sequin, P.A., Falk, R.H., Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107 (2003), 2446–2452.
35. 35 Austin, B.A., Tang, W.H., Rodriguez, E.R., et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. J Am Coll Cardiol Img 2 (2009), 1369–1377.
36. 36 White, J.A., Kim, H.W., Shah, D., et al. CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. J Am Coll Cardiol Img 7 (2014), 143–156.
37. 37 Karamitsos, T.D., Piechnik, S.K., Banypersad, S.M., et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. J Am Coll Cardiol Img 6 (2013), 488–497.
38. 38 Mongeon, F.P., Jerosch-Herold, M., Coelho-Filho, O.R., Blankstein, R., Falk, R.H., Kwong, R.Y., Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. J Am Coll Cardiol Img 5 (2012), 897–907.